title: Cutaneous CD8+ T-cell infiltrates associated with human immunodeficiency virus.
authors.forename: T
authors.initials: T
authors.lastname: Fernández-Morano
authors.forename: M
authors.initials: M
authors.lastname: Aguilar-Bernier
authors.forename: J
authors.initials: J
authors.lastname: Del Boz
authors.forename: R
authors.initials: R
authors.lastname: Fúnez-Liébana
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000505:Alopecia / Q000209:etiology; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003937:Diagnosis, Differential; D000068679:Emtricitabine; D015658:HIV Infections / Q000150:complications* / Q000276:immunology; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D019310:Pseudolymphoma / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology / Q000473:pathology; D011725:Pyridines / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D012867:Skin / Q000276:immunology / Q000473:pathology*; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D000945:Antigens, Differentiation, T-Lymphocyte; D009842:Oligopeptides; D063065:Organophosphonates; D011725:Pyridines; D003841:Deoxycytidine; D000069446:Atazanavir Sulfate; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine; D019438:Ritonavir; D011241:Prednisone